Description
AG13958 is a VEGF inhibitor in clinical development by Pfizer for treatment of age-related macular degeneration.
Alias
CD309, FLK1, VEGFR, VEGFR2
Product Overview
VEGF inhibito
Stability
2 years -20 centigrade Powder
1 month -4 centigrade in DMSO
More than one month -80 centigrade in DMSO
Synonyms
CD309, FLK1, VEGFR, VEGFR2
Molecular Formula
C26H22FN7O
Chemical Name
(E)-N-(2-fluoro-5-(3-(2-(pyridin-2-yl)vinyl)-1H-indazol-6-ylam
ino)phenyl)-1,3-dimethyl-1H-pyrazole-5-carboxamide
Solubility
DMSO > 112mg/mL Water >1mg/mL Ethanol > 4mg/mL
Download Datasheet